Birchview Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $657K | Hold |
21,000
| – | – | 0.65% | 34 |
|
|
2025
Q1 | $705K | Buy |
21,000
+11,000
| +110% | +$369K | 0.61% | 26 |
|
|
2024
Q4 | $392K | Hold |
10,000
| – | – | 0.32% | 39 |
|
|
2024
Q3 | $394K | Hold |
10,000
| – | – | 0.34% | 34 |
|
|
2024
Q2 | $390K | Hold |
10,000
| – | – | 0.36% | 37 |
|
|
2024
Q1 | $431K | Hold |
10,000
| – | – | 0.35% | 37 |
|
|
2023
Q4 | $461K | Hold |
10,000
| – | – | 0.36% | 35 |
|
|
2023
Q3 | $342K | Hold |
10,000
| – | – | 0.29% | 37 |
|
|
2023
Q2 | $385K | Hold |
10,000
| – | – | 0.29% | 38 |
|
|
2023
Q1 | $358K | Hold |
10,000
| – | – | 0.28% | 37 |
|
|
2022
Q4 | $394K | Hold |
10,000
| – | – | 0.28% | 38 |
|
|
2022
Q3 | $361K | Hold |
10,000
| – | – | 0.25% | 45 |
|
|
2022
Q2 | $304K | Buy |
+10,000
| New | +$304K | 0.22% | 46 |
|